BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26921249)

  • 1. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.
    Zhang J; Wang G; Chu SJ; Zhu JS; Zhang R; Lu WW; Xia LQ; Lu YM; Da W; Sun Q
    Oncotarget; 2016 Mar; 7(13):16180-93. PubMed ID: 26921249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.
    Ye XY; Luo QQ; Xu YH; Tang NW; Niu XM; Li ZM; Shen SP; Lu S; Chen ZW
    J Cell Mol Med; 2015 Mar; 19(3):651-63. PubMed ID: 25712415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
    Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
    Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.
    Ni W; Zhang Y; Zhan Z; Ye F; Liang Y; Huang J; Chen K; Chen L; Ding Y
    J Hematol Oncol; 2017 Apr; 10(1):91. PubMed ID: 28420424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway.
    Gao Y; Li J; Xi H; Cui J; Zhang K; Zhang J; Zhang Y; Xu W; Liang W; Zhuang Z; Wang P; Qiao Z; Wei B; Chen L
    Br J Cancer; 2020 Jun; 122(12):1837-1847. PubMed ID: 32350414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
    Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
    Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
    Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.
    Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E
    Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
    Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
    Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.
    Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G
    Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis.
    Zhang J; Xu ZP; Yang YC; Zhu JS; Zhou Z; Chen WX
    Int J Immunopathol Pharmacol; 2012; 25(3):583-90. PubMed ID: 23058008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LATS1 suppresses proliferation and invasion of cervical cancer.
    Deng J; Zhang W; Liu S; An H; Tan L; Ma L
    Mol Med Rep; 2017 Apr; 15(4):1654-1660. PubMed ID: 28259899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity.
    Yin K; Dang S; Cui L; Fan X; Wang L; Xie R; Qu J; Shang M; Chen J; Xu Z
    Biochem Biophys Res Commun; 2018 Jan; 496(1):76-82. PubMed ID: 29305865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.
    Wang C; Zhu ZM; Liu CL; He XJ; Zhang HY; Dong JH
    Mol Med Rep; 2015 Jun; 11(6):4101-8. PubMed ID: 25625370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.
    Sharif GM; Schmidt MO; Yi C; Hu Z; Haddad BR; Glasgow E; Riegel AT; Wellstein A
    Oncogene; 2015 Nov; 34(48):5879-89. PubMed ID: 25772246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.